A Study to evaluate the effect of Tiktaka ghrita and Rajanyadi churna over behavioural therapy in children with Attention deficit hyperactivity disorder of age 4 to 12 years.

Non Randomized controlled clinical trial to evaluate the effect of Tiktaka ghrita and Rajanyadi churna internally over behavioural therapy in children with Attention deficit hyperactivity disorder aged 4 to 12 years. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101144

Enrollment

Registered

2026-01-14

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children diagnosed with Attention deficit hyperactivity disorder of the age group of 4 to 12 years according to DSM 5 criteria.

Exclusion criteria

Exclusion criteria: 1. Children taking polytherapy for epilepsy. 2. Children with recurrent respiratory tract infections, three or more episodes in six-month period or more than six infections in a year. 3. Children diagnosed with inborn error of metabolism. 4. Known case of other chronic systemic illness. 5. Diagnosed with GI issues due to Other systemic causes. The exclusion is based on clinical features, history of illness along with available investigation report.

Design outcomes

Primary

Measure	Time frame
Evaluate the changes in features of hyperactivity, inattention, impulsivity using ADHDT2 rating scale and Conner s parent rating scale.Timepoint: 0th, 61st	—

Secondary

Measure	Time frame
GSSS [Gastrointestinal symptoms severity scale] to observe changes in GI features associated with ADHD. To observe the association between ADHD and inflammatory markers using Peripheral inflammatory markers like neutrophile-to lymphocyte ratio [NLR], monocyte-to-lymphocyte ratio [MLR], platelet-to lymphocyte ratio [PLR],CRP, IL6, TNF-alpha using blood samples.Timepoint: 0th, 61st	—

Countries

India

Contacts

Public ContactDr Lekshmi M K

Government Ayurveda College, Thiruvananthapuram

lekshmimk@gmail.com9447160628

Outcome results